Y-mAbs Therapeutics
YMAB
#8247
Rank
A$0.28 B
Marketcap
$6.41
Share price
-0.73%
Change (1 day)
-71.94%
Change (1 year)

Revenue for Y-mAbs Therapeutics (YMAB)

Revenue in 2024 (TTM): A$0.13 Billion

According to Y-mAbs Therapeutics 's latest financial reports the company's current revenue (TTM ) is A$0.13 Billion. an increase over the revenue in the year 2023 that were of A$0.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Y-mAbs Therapeutics from 2018 to 2024

Annual revenue

Year Revenue Change
2024 A$0.14 B13.23%
2023 A$0.12 B29.81%
2022 A$95.9 M99.25%
2021 A$48.13 M78.37%
2020 A$26.98 M
2019 N/A
2018 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA